PeptideAA Water
0.9% Benzyl Alcohol Preserved Water. Sterile. 10ml vial.

Long-acting GLP-1 receptor agonist analogue. Lyophilized.
In Stock
Semaglutide is a synthetic 31-amino-acid analogue of glucagon-like peptide-1 (GLP-1) with substitutions and a fatty-acid moiety that confer extended albumin-binding stability in research preparations.
It is a reference long-acting GLP-1 receptor agonist in preclinical metabolic-research literature.
Lyophilized under inert atmosphere. Reconstitute with sterile bacteriostatic water; store reconstituted samples refrigerated. For laboratory and research use only. Not for human or veterinary use.
Every batch of Semaglutide is independently tested by a third-party laboratory. Certificates of Analysis include HPLC purity testing, mass spectrometry confirmation, and sterility verification.
Contact us at info@spartalabs.net to request the COA for this product.
Orders are processed within 1–2 business days. Standard shipping typically takes 3–5 business days within the continental United States.
All products are shipped in temperature-controlled, discreet packaging to ensure product integrity.
Semaglutide is a synthetic 31-amino-acid analogue of glucagon-like peptide-1 (GLP-1) with substitutions and a fatty-acid moiety that confer extended albumin-binding stability in research preparations.
It is a reference long-acting GLP-1 receptor agonist in preclinical metabolic-research literature.
Lyophilized under inert atmosphere. Reconstitute with sterile bacteriostatic water; store reconstituted samples refrigerated. For laboratory and research use only. Not for human or veterinary use.
No reviews yet. Be the first verified buyer to share your experience from your account → orders page after your shipment arrives.
Reviews are open to verified buyers from your account → orders page. Every submission is moderated for compliance — we filter human-use and medical claims evenhandedly across positive and negative reviews. See our review moderation policy for the exact rules and 1–2 business-day review window.
Peptide0.9% Benzyl Alcohol Preserved Water. Sterile. 10ml vial.
PeptideBacteriostatic Water for Research. Sterile. 10ml vial.
PeptideTetra-substituted GHRH analogue with Drug Affinity Complex. Lyophilized.
PeptideCo-lyophilized 10 mg BPC-157 / 10 mg TB-500. ≥ 99% purity.
PeptideFour-peptide blend: GHK-Cu, TB-500, BPC-157, KPV. 80 mg total. Lyophilized.
PeptideCo-lyophilized 5 mg BPC-157 / 5 mg TB-500. ≥ 99% purity.
PeptideSynthetic hexapeptide ghrelin-receptor agonist. Lyophilized.
PeptideSynthetic tetrapeptide (Ala-Glu-Asp-Gly). Lyophilized.
PeptideSynthetic pentadecapeptide. Lyophilized. ≥ 99% purity.
PeptideLong-acting amylin analogue. Lyophilized. ≥ 99% purity.
PeptideTetra-substituted GHRH (1-29) analogue, no DAC. Lyophilized. ≥ 99% purity.
PeptideModified C-terminal fragment (Tyr-hGH 177-191) of human growth hormone. Lyophilized.
How SpartaLabs sources, tests, and verifies semaglutide for research applications. Educational reference.
A bibliographic summary of peer-reviewed clinical research on semaglutide, covering the SUSTAIN, PIONEER, STEP, and SELECT trial programs, with methodology descriptions and reported findings attributed to their primary sources.
An educational reference covering the chemistry, pharmacological classification, and regulatory history of semaglutide, a long-acting glucagon-like peptide-1 receptor agonist developed at Novo Nordisk.
A research reference describing the reported molecular interactions, receptor-signaling pathways, and downstream pharmacological effects of semaglutide at the glucagon-like peptide-1 receptor, as characterized in published literature.
A chronological account of the scientific discoveries, structural engineering milestones, and regulatory events that led from the identification of glucagon-like peptide-1 in the 1980s to the development and regulatory authorization of semaglutide across multiple indications.